ミノキシジル ： 円形脱毛症

References

1. [1] Michael M Ong et al.. Am J Clin Dermatol. 2026. Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations. doi:10.1007/s40257-025-00990-4 PubMed
2. [2] Caitlin A Kearney et al.. Am J Clin Dermatol. 2026. Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. doi:10.1007/s40257-026-01009-2 PubMed
3. [3] Zulin Wan et al.. Front Immunol. 2026. Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review. doi:10.3389/fimmu.2026.1766847 PubMed
4. [4] Eric McMullen et al.. Int J Dermatol. 2026. Combined Low Dose Oral Minoxidil and Immunomodulator Efficacy and Safety in Alopecia Areata: A Systematic Review. doi:10.1111/ijd.70194 PubMed
5. [5] Jair Alejandro Valdez-Zertuche et al.. Expert Opin Drug Metab Toxicol. 2025. Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review. doi:10.1080/17425255.2025.2461483 PubMed
6. [6] Yozahandy A Abarca et al.. Cureus. 2025. Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities. doi:10.7759/cureus.78298 PubMed
7. [7] Sarah Schaffer et al.. Cureus. 2025. A Scoping Review of Exosome Delivery Applications in Hair Loss. doi:10.7759/cureus.81152 PubMed
8. [8] Luiza Kalil et al.. Dermatol Clin. 2025. Innovation in Alopecia Areata. doi:10.1016/j.det.2024.09.001 PubMed
9. [9] Luiza Kalil et al.. Pediatr Dermatol. 2025. Systemic Therapies for Pediatric Alopecia Areata. doi:10.1111/pde.15822 PubMed
10. [10] Kailyn Valido et al.. J Am Acad Dermatol. 2025. Baricitinib and oral minoxidil for the treatment of alopecia areata in pediatric patients. doi:10.1016/j.jaad.2025.03.085 PubMed
11. [11] Rui Wang et al.. Drug Dev Res. 2025. A Novel Topical Compound Gel Loading Minoxidil and Tofacitinib for Treatment of Alopecia Areata: Formulation, Characterization, and In Vitro/In Vivo … doi:10.1002/ddr.70076 PubMed
12. [12] Luiza Kalil et al.. J Am Acad Dermatol. 2025. Oral minoxidil treatment of alopecia areata. doi:10.1016/j.jaad.2025.05.1446 PubMed
13. [13] Xuexue Pan et al.. Aesthetic Plast Surg. 2025. Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation. doi:10.1007/s00266-025-05077-3 PubMed
14. [14] Rui-Xian Guo et al.. Front Pharmacol. 2025. Research progress in the treatment of non-scarring alopecia: mechanism and treatment. doi:10.3389/fphar.2025.1544068 PubMed
15. [15] Kailyn Valido et al.. J Am Acad Dermatol. 2025. Combination oral minoxidil and baricitinib treatment of alopecia areata. doi:10.1016/j.jaad.2025.05.1393 PubMed
16. [16] Farheen Begum et al.. Indian Dermatol Online J. 2025. Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with … doi:10.4103/idoj.idoj_913_23 PubMed
17. [17] Carli D Needle et al.. Int J Dermatol. 2025. Alopecia Treatments in Breastfeeding: Safety and Clinical Considerations. doi:10.1111/ijd.17940 PubMed
18. [18] Ana Melián-Olivera et al.. J Clin Med. 2025. Frontal Fibrosing Alopecia in Men: A Review of the Literature. doi:10.3390/jcm14061914 PubMed
19. [19] Esraa Elsayed Elhawary et al.. Lasers Surg Med. 2025. Fractional CO2 Laser and Minoxidil in the Treatment of Alopecia Areata, A Comparative Study. doi:10.1002/lsm.23876 PubMed
20. [20] Alondra Saray Polanco-Llanes et al.. Cureus. 2025. Plica Neuropathica (Polonica) Secondary to Diffuse Alopecia: A Case Report and Literature Review. doi:10.7759/cureus.93402 PubMed
21. [21] Robert J Vanaria et al.. J Cosmet Dermatol. 2025. The Use of Light-Based Therapies in the Treatment of Alopecia. doi:10.1111/jocd.70434 PubMed
22. [22] Juan Jimenez-Cauhe et al.. J Am Acad Dermatol. 2025. Combination of oral minoxidil and baricitinib for alopecia areata: A retrospective study of 77 patients. doi:10.1016/j.jaad.2025.10.157 PubMed
23. [23] Carli D Needle et al.. Arch Dermatol Res. 2025. Key considerations of injectable minoxidil for alopecia. doi:10.1007/s00403-025-04068-3 PubMed
24. [24] Aliyyat Afolabi et al.. Telemed Rep. 2025. Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study. doi:10.1177/26924366251366793 PubMed
25. [25] Adam Leavitt et al.. J Drugs Dermatol. 2025. Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions. doi:10.36849/JDD.8763 PubMed
26. [26] L Rudnicka et al.. J Eur Acad Dermatol Venereol. 2024. European expert consensus statement on the systemic treatment of alopecia areata. doi:10.1111/jdv.19768 PubMed
27. [27] Dan Liu et al.. Int J Med Sci. 2024. Status of research on the development and regeneration of hair follicles. doi:10.7150/ijms.88508 PubMed
28. [28] Mohammad Amin Jafari et al.. Health Sci Rep. 2024. Efficacy and Safety of Laser Therapy and Phototherapy in Cicatricial and NonCicatricial Alopecia: A Systematic Review Study. doi:10.1002/hsr2.70180 PubMed
29. [29] Eliza Balazic et al.. Lasers Med Sci. 2024. The role of laser and energy-assisted drug delivery in the treatment of alopecia. doi:10.1007/s10103-024-04015-0 PubMed
30. [30] Linnea L Westerkam et al.. Paediatr Drugs. 2024. Treatment Options for Alopecia Areata in Children and Adolescents. doi:10.1007/s40272-024-00620-2 PubMed
31. [31] Michał Majewski et al.. J Clin Med. 2024. The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis. doi:10.3390/jcm13247712 PubMed
32. [32] MaryAnn Dakkak et al.. Am Fam Physician. 2024. Hair Loss: Diagnosis and Treatment. PubMed
33. [33] Ramadan S Hussein et al.. Skin Health Dis. 2024. Applications and efficacy of minoxidil in dermatology. doi:10.1002/ski2.472 PubMed
34. [34] Ruchi S Raval et al.. J Am Acad Dermatol. 2024. The use of minoxidil in the treatment of alopecia areata: A systematic review. doi:10.1016/j.jaad.2024.05.037 PubMed
35. [35] Aarushi K Parikh et al.. Life (Basel). 2024. Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia. doi:10.3390/life14121577 PubMed
36. [36] Fanglin Wei et al.. Skin Res Technol. 2024. Effect of minoxidil combined with triamcinolone acetonide on alopecia areata by microneedle injection. doi:10.1111/srt.13713 PubMed
37. [37] Anjum Muhammad et al.. Cureus. 2024. Comparison of Efficacy of Autologous Platelet Rich Plasma Therapy With 5% Topical Minoxidil Spray in Treating Alopecia Areata: A Head-to-Head … doi:10.7759/cureus.61878 PubMed
38. [38] Rabia Ghafoor et al.. J Coll Physicians Surg Pak. 2024. The Role of 5% Minoxidil <em>versus</em> Platelet-Rich Plasma in Treatment of Alopecia Areata. doi:10.29271/jcpsp.2024.06.650 PubMed
39. [39] Yutong Xie et al.. J Dermatolog Treat. 2024. Cosmetic filler-induced hair loss: case series and literature review. doi:10.1080/09546634.2024.2443111 PubMed
40. [40] Sana Aslam et al.. Cureus. 2024. Comparison of Efficacy of Topical Betamethasone Dipropionate and Topical Minoxidil in Patients With Alopecia Areata. doi:10.7759/cureus.56282 PubMed
41. [41] Chenqi Guo et al.. J Dermatolog Treat. 2024. Efficacy and safety of compound glycyrrhizin combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized … doi:10.1080/09546634.2024.2381766 PubMed
42. [42] Brittany Feaster et al.. Arch Dermatol Res. 2023. Oral minoxidil use in androgenetic alopecia and telogen effluvium. doi:10.1007/s00403-022-02331-5 PubMed
43. [43] Breno N Matos et al.. Pharmaceuticals (Basel). 2023. Follicle-Targeted Delivery of Betamethasone and Minoxidil Co-Entrapped in Polymeric and Lipid Nanoparticles for Topical Alopecia Areata Treatment. doi:10.3390/ph16091322 PubMed
44. [44] Jianfeng Zhang et al.. Lasers Med Sci. 2023. Laser and light therapy combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials. doi:10.1007/s10103-023-03734-0 PubMed
45. [45] Michelle Fuschlberger et al.. Sci Rep. 2023. Vitamin B12 supplementation and health behavior of Austrian vegans: a cross-sectional online survey. doi:10.1038/s41598-023-30843-1 PubMed
46. [46] Rita Fernanda Cortez de Almeida et al.. Skin Appendage Disord. 2023. Scalp Microinfusion: A Novel Drug Delivery Technique for Hair Loss Treatment. doi:10.1159/000528446 PubMed
47. [47] S Cedirian et al.. J Cosmet Dermatol. 2023. Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic … doi:10.1111/jocd.15873 PubMed
48. [48] Michela Starace et al.. Ital J Dermatol Venerol. 2023. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic … doi:10.23736/S2784-8671.22.07416-3 PubMed
49. [49] Daranporn Triwongwaranat et al.. Medicine (Baltimore). 2023. Characteristics of hair loss in COVID-19 patients in Thailand. doi:10.1097/MD.0000000000036539 PubMed
50. [50] Ji Won Lee et al.. J Dermatol. 2023. Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series. doi:10.1111/1346-8138.16715 PubMed
51. [51] Yuqing Shen et al.. J Cosmet Dermatol. 2023. Effect of fractional laser alone or in combination on alopecia areata: A systematic review and meta-analysis. doi:10.1111/jocd.15630 PubMed
52. [52] Miriam Mateos-Haro et al.. Cochrane Database Syst Rev. 2023. Treatments for alopecia areata: a network meta-analysis. doi:10.1002/14651858.CD013719.pub2 PubMed
53. [53] Monica Păun et al.. Medicina (Kaunas). 2023. Epidemiologic Study of Gene Distribution in Romanian and Brazilian Patients with Non-Cicatricial Alopecia. doi:10.3390/medicina59091654 PubMed
54. [54] A K Gupta et al.. J Dermatolog Treat. 2022. Minoxidil: a comprehensive review. doi:10.1080/09546634.2021.1945527 PubMed
55. [55] Virginia R Barton et al.. J Am Acad Dermatol. 2022. Treatment of pediatric alopecia areata: A systematic review. doi:10.1016/j.jaad.2021.04.077 PubMed
56. [56] Robert S English et al.. Dermatol Ther (Heidelb). 2022. Microneedling and Its Use in Hair Loss Disorders: A Systematic Review. doi:10.1007/s13555-021-00653-2 PubMed
57. [57] Talagavadi Channaiah Anudeep et al.. Pharmaceutics. 2022. Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia. doi:10.3390/pharmaceutics14030612 PubMed
58. [58] Dong Wook Shin. Korean J Physiol Pharmacol. 2022. The physiological and pharmacological roles of prostaglandins in hair growth. doi:10.4196/kjpp.2022.26.6.405 PubMed
59. [59] Belen de Nicolas-Ruanes et al.. J Am Acad Dermatol. 2022. Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a pediatric population: A descriptive study. doi:10.1016/j.jaad.2022.04.030 PubMed
60. [60] Manabu Ohyama et al.. J Dermatol. 2022. Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better … doi:10.1111/1346-8138.16475 PubMed
61. [61] Mahmoud Abd El-Rahim Abdallah et al.. J Dermatolog Treat. 2022. Efficacy of intradermal minoxidil 5% injections for treatment of patchy non-severe alopecia areata. doi:10.1080/09546634.2020.1793893 PubMed
62. [62] Fabrizio Martora et al.. Skin Appendage Disord. 2022. Oral Minoxidil for Chemotherapy-Induced Alopecia. doi:10.1159/000525463 PubMed
63. [63] Samir Kumar Praharaj et al.. Hum Psychopharmacol. 2022. Valproate-associated hair abnormalities: Pathophysiology and management strategies. doi:10.1002/hup.2814 PubMed
64. [64] Dalia Mahmoud Toma et al.. Dermatol Ther. 2022. Comparative study between topical methotrexate 1% gel and minoxidil 5% gel in the treatment of localized alopecia areata. doi:10.1111/dth.15696 PubMed
65. [65] Elizabeth Klein et al.. J Drugs Dermatol. 2022. Reversible Hair Loss in Lichen Planopilaris: Regrowth With Low-Dose Naltrexone and Platelet-Rich Plasma. doi:10.36849/JDD.6810 PubMed
66. [66] Ronan Talty et al.. JAAD Case Rep. 2022. Sisaipho alopecia areata treated with tofacitinib and oral minoxidil. doi:10.1016/j.jdcr.2022.08.037 PubMed
67. [67] Danchen Hu et al.. Am J Dermatopathol. 2022. Rare Concurrence of Alopecia Areata in the Setting of the Lipedematous Scalp. doi:10.1097/DAD.0000000000002261 PubMed
68. [68] Mark S Nestor et al.. J Cosmet Dermatol. 2021. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. doi:10.1111/jocd.14537 PubMed
69. [69] Cheng Zhou et al.. Clin Rev Allergy Immunol. 2021. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management. doi:10.1007/s12016-021-08883-0 PubMed
70. [70] Michael Randolph et al.. J Am Acad Dermatol. 2021. Oral minoxidil treatment for hair loss: A review of efficacy and safety. doi:10.1016/j.jaad.2020.06.1009 PubMed
71. [71] A Sterkens et al.. Clin Exp Med. 2021. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options. doi:10.1007/s10238-020-00673-w PubMed
72. [72] Carlos G Wambier et al.. J Am Acad Dermatol. 2021. Combination tofacitinib and oral minoxidil treatment for severe alopecia areata. doi:10.1016/j.jaad.2019.08.080 PubMed
73. [73] A Villani et al.. J Eur Acad Dermatol Venereol. 2021. Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose. doi:10.1111/jdv.17216 PubMed
74. [74] Masoumeh Roohaninasab et al.. Dermatol Ther. 2021. Systematic review of platelet-rich plasma in treating alopecia: Focusing on efficacy, safety, and therapeutic durability. doi:10.1111/dth.14768 PubMed
75. [75] Ginny Oong Chien Yin et al.. J Dermatol Sci. 2021. Telogen Effluvium - a review of the science and current obstacles. doi:10.1016/j.jdermsci.2021.01.007 PubMed
76. [76] Bevin Bhoyrul et al.. JAMA Dermatol. 2021. Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors. doi:10.1001/jamadermatol.2021.3676 PubMed
77. [77] Takeshi Fukumoto et al.. Dermatol Ther. 2021. Treatments for alopecia areata: A systematic review and network meta-analysis. doi:10.1111/dth.14916 PubMed
78. [78] Michela Starace et al.. Am J Clin Dermatol. 2020. Female Androgenetic Alopecia: An Update on Diagnosis and Management. doi:10.1007/s40257-019-00479-x PubMed
79. [79] Ajay N Sharma et al.. Int J Dermatol. 2020. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. doi:10.1111/ijd.14933 PubMed
80. [80] Chauncey C Barbulescu et al.. J Invest Dermatol. 2020. Harnessing the Power of Regenerative Therapy for Vitiligo and Alopecia Areata. doi:10.1016/j.jid.2019.03.1142 PubMed
81. [81] Kam L Hon et al.. Recent Pat Inflamm Allergy Drug Discov. 2020. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents. doi:10.2174/1872213X14999200728145822 PubMed
82. [82] Maria K Hordinsky. J Investig Dermatol Symp Proc. 2020. Current Treatment of Alopecia Areata. doi:10.1016/j.jisp.2020.04.004 PubMed
83. [83] William C Cranwell et al.. Australas J Dermatol. 2019. Treatment of alopecia areata: An Australian expert consensus statement. doi:10.1111/ajd.12941 PubMed
84. [84] Jenna R Stoehr et al.. Am J Clin Dermatol. 2019. Off-Label Use of Topical Minoxidil in Alopecia: A Review. doi:10.1007/s40257-018-0409-y PubMed
85. [85] P C B Freire et al.. J Eur Acad Dermatol Venereol. 2019. Minoxidil for patchy alopecia areata: systematic review and meta-analysis. doi:10.1111/jdv.15545 PubMed
86. [86] Jorge Ocampo-Garza et al.. Expert Opin Investig Drugs. 2019. New drugs under investigation for the treatment of alopecias. doi:10.1080/13543784.2019.1568989 PubMed
87. [87] Calvin T. Sung et al.. J Drugs Dermatol. 2019. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review. PubMed
88. [88] Angela Wipf et al.. J Cosmet Laser Ther. 2019. The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards … doi:10.1080/14764172.2018.1525743 PubMed
89. [89] Eduardo Anitua et al.. J Cosmet Dermatol. 2019. Platelet rich plasma for the management of hair loss: Better alone or in combination? doi:10.1111/jocd.12683 PubMed
90. [90] Hana Jedličková et al.. Klin Onkol. 2019. Alopecia and Hair Damage Induced by Oncological Therapy. doi:10.14735/amko2019353 PubMed
91. [91] Lauren C Strazzulla et al.. J Am Acad Dermatol. 2018. Alopecia areata: An appraisal of new treatment approaches and overview of current therapies. doi:10.1016/j.jaad.2017.04.1142 PubMed
92. [92] R M Fertig et al.. J Eur Acad Dermatol Venereol. 2018. Microneedling for the treatment of hair loss? doi:10.1111/jdv.14722 PubMed
93. [93] Bu Young Choi. Int J Mol Sci. 2018. Hair-Growth Potential of Ginseng and Its Major Metabolites: A Review on Its Molecular Mechanisms. doi:10.3390/ijms19092703 PubMed
94. [94] Erkin Pekmezci et al.. Med Arch. 2018. Proprietary Herbal Extract Downregulates the Gene Expression of IL-1α in HaCaT Cells: Possible Implications Against Nonscarring Alopecia. doi:10.5455/medarh.2018.72.136-140 PubMed
95. [95] Ibrahim Najem et al.. J Cosmet Laser Ther. 2018. Use of low-level laser therapy in treatment of the androgenic alopecia, the first systematic review. doi:10.1080/14764172.2017.1400174 PubMed
96. [96] A Gomez-Zubiaur et al.. Dermatol Online J. 2018. [Not Available]. PubMed
97. [97] T Grant Phillips et al.. Am Fam Physician. 2017. Hair Loss: Common Causes and Treatment. PubMed
98. [98] Moustafa A El Taieb et al.. Dermatol Ther. 2017. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation. doi:10.1111/dth.12437 PubMed
99. [99] Marina Perper et al.. Lasers Med Sci. 2017. Efficacy of fractional lasers in treating alopecia: a literature review. doi:10.1007/s10103-017-2306-7 PubMed
100. [100] Aditya K Gupta et al.. Am J Clin Dermatol. 2017. Treating Alopecia Areata: Current Practices Versus New Directions. doi:10.1007/s40257-016-0230-4 PubMed
101. [101] S Vañó-Galván et al.. Actas Dermosifiliogr. 2017. New Treatments for Hair Loss. doi:10.1016/j.ad.2016.11.010 PubMed
102. [102] Hans Wolff et al.. Dtsch Arztebl Int. 2016. The Diagnosis and Treatment of Hair and Scalp Diseases. doi:10.3238/arztebl.2016.0377 PubMed
103. [103] Juliany Estefan et al.. Skinmed. 2016. Alopecia Areata-Part III: Prognosis and Treatment. PubMed
104. [104] Eshini Perera et al.. Curr Probl Dermatol. 2015. Alopecia areata. doi:10.1159/000369406 PubMed
105. [105] Jay C Vary. Med Clin North Am. 2015. Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis. doi:10.1016/j.mcna.2015.07.003 PubMed
106. [106] Frank Spano et al.. Can Fam Physician. 2015. Alopecia areata: Part 2: treatment. PubMed
107. [107] Fernanda Torres et al.. Semin Cutan Med Surg. 2015. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia. doi:10.12788/j.sder.2015.0142 PubMed
108. [108] Maria K Hordinsky. J Investig Dermatol Symp Proc. 2015. Current Treatments for Alopecia Areata. doi:10.1038/jidsymp.2015.41 PubMed
109. [109] Rubina Alves et al.. Curr Probl Dermatol. 2015. Hair loss in children. doi:10.1159/000369405 PubMed
110. [110] H Wolff. Internist (Berl). 2015. [Drug treatment of alopecia]. doi:10.1007/s00108-015-3763-3 PubMed
111. [111] Pinar Avci et al.. Lasers Surg Med. 2014. Low-level laser (light) therapy (LLLT) for treatment of hair loss. doi:10.1002/lsm.22170 PubMed
112. [112] Maria Hordinsky et al.. Am J Clin Dermatol. 2014. Alopecia areata: an evidence-based treatment update. doi:10.1007/s40257-014-0086-4 PubMed
113. [113] Leyre Falto-Aizpurua et al.. Expert Opin Emerg Drugs. 2014. Emerging treatments in alopecia. doi:10.1517/14728214.2014.974550 PubMed
114. [114] A Rebora. G Ital Dermatol Venereol. 2014. Telogen effluvium revisited. PubMed
115. [115] A Rossi et al.. G Ital Dermatol Venereol. 2014. Treatment for alopecia. PubMed
116. [116] Ingrid Herskovitz et al.. Int J Endocrinol Metab. 2013. Female pattern hair loss. doi:10.5812/ijem.9860 PubMed
117. [117] Kam-Lun E Hon et al.. Recent Pat Inflamm Allergy Drug Discov. 2011. Alopecia areata. doi:10.2174/187221311795399291 PubMed
118. [118] Seema Garg et al.. Semin Cutan Med Surg. 2009. Alopecia areata: evidence-based treatments. doi:10.1016/j.sder.2008.12.002 PubMed
119. [119] Anne L Mounsey et al.. Am Fam Physician. 2009. Diagnosing and treating hair loss. PubMed
120. [120] F M Delamere et al.. Cochrane Database Syst Rev. 2008. Interventions for alopecia areata. doi:10.1002/14651858.CD004413.pub2 PubMed
121. [121] Laleh A Bedocs et al.. Curr Opin Pediatr. 2008. Adolescent hair loss. doi:10.1097/MOP.0b013e328305e285 PubMed
122. [122] Dan Wasserman et al.. Int J Dermatol. 2007. Alopecia areata. doi:10.1111/j.1365-4632.2007.03193.x PubMed
123. [123] Paul T Martinelli et al.. Dermatol Nurs. 2007. Alopecia areata. PubMed
124. [124] Rhonda A Kwong et al.. Australas J Dermatol. 2006. Alopecia areata masquerading as frontal fibrosing alopecia. doi:10.1111/j.1440-0960.2006.00227.x PubMed
125. [125] Patsy Lenane et al.. J Am Acad Dermatol. 2005. Congenital alopecia areata. doi:10.1016/j.jaad.2004.06.024 PubMed
126. [126] Nicole C Dombrowski et al.. Cleve Clin J Med. 2005. Alopecia areata: what to expect from current treatments. doi:10.3949/ccjm.72.9.758 PubMed
127. [127] R M Trüeb. Praxis (Bern 1994). 2003. [Hair loss]. doi:10.1024/0369-8394.92.36.1488 PubMed
128. [128] C Carolyn Thiedke. Am Fam Physician. 2003. Alopecia in women. PubMed
129. [129] Karyn Springer et al.. Am Fam Physician. 2003. Common hair loss disorders. PubMed
130. [130] V M Meidan et al.. Drugs. 2001. Treatments for androgenetic alopecia and alopecia areata: current options and future prospects. doi:10.2165/00003495-200161010-00006 PubMed
131. [131] A J Papadopoulos et al.. Am J Clin Dermatol. 2000. Alopecia areata. Pathogenesis, diagnosis, and therapy. doi:10.2165/00128071-200001020-00004 PubMed
132. [132] M Sommer et al.. Int J Clin Pract. 1999. Therapeutic approaches to the management of common baldness. PubMed
133. [133] J Shapiro et al.. Dermatol Clin. 1998. Hair regrowth. Therapeutic agents. doi:10.1016/s0733-8635(05)70017-6 PubMed
134. [134] E L Khoury et al.. J Invest Dermatol. 1992. Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration. doi:10.1111/1523-1747.ep12611409 PubMed
135. [135] E A Olsen et al.. Arch Dermatol. 1992. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. PubMed
136. [136] J M Weitzner. Am Fam Physician. 1990. Alopecia areata. PubMed
137. [137] S P Clissold et al.. Drugs. 1987. Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica. doi:10.2165/00003495-198733020-00002 PubMed
138. [138] V C Fiedler-Weiss. Dermatol Clin. 1987. Minoxidil. PubMed
139. [139] A J Mitchell et al.. J Am Acad Dermatol. 1984. Alopecia areata: pathogenesis and treatment. doi:10.1016/s0190-9622(84)80450-8 PubMed
140. [140] E E Vanderveen et al.. J Am Acad Dermatol. 1984. Topical minoxidil for hair regrowth. doi:10.1016/s0190-9622(84)70183-6 PubMed
141. [141] V C Weiss et al.. Arch Dermatol. 1984. Alopecia areata treated with topical minoxidil. PubMed